{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T03:11:54Z","timestamp":1775185914870,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.vaccine.2023.06.015","type":"journal-article","created":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T12:12:45Z","timestamp":1686053565000},"page":"4743-4751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Protective immunity induced by an inhaled SARS-CoV-2 subunit vaccine"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1615-2642","authenticated-orcid":false,"given":"Elizabeth","family":"Elder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandrashekar","family":"Bangalore Revanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catharina","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.A.","family":"Wallin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4954-7157","authenticated-orcid":false,"given":"Johan","family":"Sj\u00f6dahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ola","family":"Winqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Mirazimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.06.015_b0005","article-title":"Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis","author":"Zheng","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2023.06.015_b0010","article-title":"Counting on COVID-19 vaccine: insights into the current strategies","volume":"9","author":"Kandimalla","year":"2021","journal-title":"Progrand Fut Challen Biomed"},{"issue":"12","key":"10.1016\/j.vaccine.2023.06.015_b0015","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S2213-2600(21)00407-0","article-title":"Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?","volume":"9","author":"Milne","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2023.06.015_b0020","first-page":"1","article-title":"COVID-19 vaccine equity: a health systems and policy perspective","author":"Van De Pas","year":"2021","journal-title":"Expert Rev Vaccines"},{"issue":"11","key":"10.1016\/j.vaccine.2023.06.015_b0025","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1016\/j.drudis.2021.07.021","article-title":"Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management","volume":"26","author":"Chavda","year":"2021","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.vaccine.2023.06.015_b0030","article-title":"Mucosal vaccines - fortifying the frontiers","author":"Lavelle","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2023.06.015_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103841","article-title":"Intranasal COVID-19 vaccines: From bench to bed","volume":"76","author":"Alu","year":"2022","journal-title":"EBioMedicine"},{"issue":"607","key":"10.1016\/j.vaccine.2023.06.015_b0040","article-title":"Intranasal ChAdOx1 nCoV-19\/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models","volume":"13","author":"Doremalen","year":"2021","journal-title":"Sci Transl Med"},{"issue":"50","key":"10.1016\/j.vaccine.2023.06.015_b0045","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.1016\/j.vaccine.2020.10.064","article-title":"NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge","volume":"38","author":"Guebre-Xabier","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.06.015_b0050","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.1c05002","article-title":"Gold-nanostar-chitosan-mediated delivery of SARS- CoV-2 DNA vaccine for respiratory mucosal immunization: development and proof-of-principle","author":"Kumar","year":"2021","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.vaccine.2023.06.015_b0055","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2020.08.026","article-title":"A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2","volume":"183","author":"Hassan","year":"2020","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.vaccine.2023.06.015_b0060","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S1473-3099(21)00396-0","article-title":"Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial","volume":"21","author":"Wu","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2023.06.015_b0065","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.148494","article-title":"Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques","volume":"6","author":"Sui","year":"2021","journal-title":"JCI Insight"},{"issue":"16","key":"10.1016\/j.vaccine.2023.06.015_b0070","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.vaccine.2021.03.006","article-title":"Intranasal administration of a recombinant RBD vaccine induced protective immunity against SARS-CoV-2 in mouse","volume":"39","author":"Du","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.06.015_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.781280","article-title":"An intranasal OMV-based vaccine induces high mucosal and systemic protecting immunity against a SARS-CoV-2 infection","volume":"12","author":"van der Ley","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2023.06.015_b0080","article-title":"Optimization of single-dose VSV-based COVID-19 vaccination in hamsters","volume":"12","author":"O'Donnell","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2023.06.015_b0085","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.vaccine.2021.12.024","article-title":"Induction of Th1 and Th2 in the protection against SARS-CoV-2 through mucosal delivery of an adenovirus vaccine expressing an engineered spike protein","volume":"40","author":"Chung","year":"2022","journal-title":"Vaccine"},{"issue":"50","key":"10.1016\/j.vaccine.2023.06.015_b0090","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109744118","article-title":"A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters","volume":"118","author":"Liu","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2023.06.015_b0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-13819-5","article-title":"Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters","volume":"12","author":"Stark","year":"2022","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2023.06.015_b0100","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.cell.2022.02.005","article-title":"Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2","volume":"185","author":"Afkhami","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2023.06.015_b0105","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114459","article-title":"Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice","author":"Ku","year":"2021","journal-title":"EMBO Mol Med"},{"issue":"3","key":"10.1016\/j.vaccine.2023.06.015_b0110","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-021-01974-3","article-title":"Next-generation COVID-19 vaccines should take efficiency of distribution into consideration","volume":"22","author":"AboulFotouh","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.vaccine.2023.06.015_b0115","first-page":"1","article-title":"Inhaled vaccine delivery in the combat against respiratory viruses: a 2021 overview of recent developments and implications for COVID-19","author":"Heida","year":"2021","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2023.06.015_b0120","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-82614-5","article-title":"The safety and efficacy of BCG encapsulated alginate particle (BEAP) against M.tb H37Rv infection in Macaca mulatta: A pilot study","volume":"11","author":"Kesarwani","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2023.06.015_b0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejpb.2017.11.001","article-title":"Intranasal immunization with dry powder vaccines","volume":"122","author":"Bahamondez-Canas","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1016\/j.vaccine.2023.06.015_b0130","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-021-00320-9","article-title":"Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets","volume":"6","author":"Luczo","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2023.06.015_b0135","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jconrel.2021.11.002","article-title":"A respirable HPV-L2 dry-powder vaccine with GLA as amphiphilic lubricant and immune-adjuvant","volume":"340","author":"Rossi","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2023.06.015_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.654165","article-title":"Immunity to SARS-CoV-2: lessons learned","volume":"12","author":"Fergie","year":"2021","journal-title":"Front Immunol"},{"issue":"6520","key":"10.1016\/j.vaccine.2023.06.015_b0145","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4250","article-title":"Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity","volume":"370","author":"Shrock","year":"2020","journal-title":"Science (New York, N.Y.)"},{"issue":"7821","key":"10.1016\/j.vaccine.2023.06.015_b0150","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals","volume":"584","author":"Robbiani","year":"2020","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.vaccine.2023.06.015_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/v13112202","article-title":"Peritoneal administration of a subunit vaccine encapsulated in a nanodelivery system not only augments systemic responses against SARS-CoV-2 but also stimulates responses in the respiratory tract","volume":"13","author":"Jearanaiwitayakul","year":"2021","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.vaccine.2023.06.015_b0160","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1128\/JVI.01702-06","article-title":"Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor","volume":"81","author":"Tseng","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.06.015_b0165","first-page":"1","article-title":"SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation","author":"Xu","year":"2021","journal-title":"Cell Res"},{"issue":"11","key":"10.1016\/j.vaccine.2023.06.015_b0170","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1128\/JVI.02272-08","article-title":"Differential virological and immunological outcome of severe acute respiratory syndrome coronavirus infection in susceptible and resistant transgenic mice expressing human angiotensin-converting enzyme 2","volume":"83","author":"Yoshikawa","year":"2009","journal-title":"J Virol"},{"issue":"7798","key":"10.1016\/j.vaccine.2023.06.015_b0175","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2023.06.015_b0180","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.00473","article-title":"Construction of a live-attenuated vaccine strain of yersinia pestis EV76-B-SHU\u0394pla and evaluation of its protection efficacy in a mouse model by aerosolized intratracheal inoculation","volume":"10","author":"Feng","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2023.06.015_b0185","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0264-410X(97)00123-0","article-title":"Liposomally-encapsulated ricin toxoid vaccine delivered intratracheally elicits a good immune response and protects against a lethal pulmonary dose of ricin toxin","volume":"15","author":"Griffiths","year":"1997","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2023.06.015_b0190","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142032","article-title":"Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease","volume":"5","author":"Golden","year":"2020","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.vaccine.2023.06.015_b0195","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1080\/22221751.2020.1838955","article-title":"Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection","volume":"9","author":"Rathnasinghe","year":"2020","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2023.06.015_b0200","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-32547-y","article-title":"Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD- Nucleocapsid fusion protein","volume":"13","author":"Castro","year":"2022","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.vaccine.2023.06.015_b0205","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/s41385-018-0006-7","article-title":"Oral cholera vaccination promotes homing of IgA(+) memory B cells to the large intestine and the respiratory tract","volume":"11","author":"van Splunter","year":"2018","journal-title":"Mucosal Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2023.06.015_b0210","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.4049\/jimmunol.123.4.1705","article-title":"Organ and isotype distribution of plasma cells producing specific antibody after oral immunization: evidence for a generalized secretory immune system","volume":"123","author":"Weisz-Carrington","year":"1979","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2023.06.015_b0215","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2209651","article-title":"Anti-spike mucosal IgA protection against SARS- CoV-2 omicron infection","author":"Havervall","year":"2022","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2023.06.015_b0220","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","article-title":"The T cell immune response against SARS-CoV-2","volume":"23","author":"Moss","year":"2022","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2023.06.015_b0225","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41423-021-00809-2","article-title":"Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates","volume":"19","author":"Pillet","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.vaccine.2023.06.015_b0230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02874","article-title":"Adjuvants enhancing cross-presentation by dendritic cells: The key to more effective vaccines?","volume":"9","author":"Ho","year":"2018","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2023.06.015_b0235","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.vaccine.2023.06.015_b0240","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1056\/NEJMc2110716","article-title":"Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination","volume":"385","author":"Normark","year":"2021","journal-title":"N Engl J Med"},{"issue":"50","key":"10.1016\/j.vaccine.2023.06.015_b0245","doi-asserted-by":"crossref","first-page":"19944","DOI":"10.1073\/pnas.0808116105","article-title":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice","volume":"105","author":"Becker","year":"2008","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2023.06.015_b0250","doi-asserted-by":"crossref","DOI":"10.1186\/2043-9113-2-5","article-title":"Monte Carlo simulation of the Spearman-Kaerber TCID50","volume":"2","author":"Wulff","year":"2012","journal-title":"J Clin Bioinf"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23006849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23006849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:28:24Z","timestamp":1759404504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23006849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":50,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0264410X23006849"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective immunity induced by an inhaled SARS-CoV-2 subunit vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}